Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies.

Insights into the workings of DNA damage response proteins such as SMARCAL1 could suggest new ways to improve genome integrity and prevent cancer.

Studies of a human polymerase that replicates DNA have provided a complete kinetic and structural framework for understanding how the enzyme accurately bypasses DNA damage.

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

Targeting the enzyme FosB could make antibiotic-resistant staph bacteria sensitive to the antibiotic fosfomycin.

Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.

The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.